The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan

Biochemical Pharmacology
Anna AlonenRisto Kostiainen


Losartan, candesartan, and zolarsartan are AT(1) receptor antagonists that inhibit the effect of angiotensin II. We have examined their glucuronidation by liver microsomes from several animals and by recombinant human UDP-glucuronosyltransferases (UGTs). Large differences in the production of different glucuronide regioisomers of the three sartans were observed among liver microsomes from human (HLM), rabbit, rat, pig, moose, and bovine. However, all the liver microsomes produced one or two N-glucuronides in which either N1 or N2 of the tetrazole ring were conjugated. O-Glucuronides were also detected, including acyl glucuronides of zolarsartan and candesartan. Examination of individual human UGTs of subfamilies 1A and 2B revealed that N-glucuronidation activity is widespread, along with variable regioselectivity with respect to the tetrazole nitrogens of these sartans. Interestingly, UGT1A3 exhibited a strong regioselectivity towards the N2 position of the tetrazole ring in all three sartans. Moreover, the tetrazole-N2 of zolarsartan was only conjugated by UGT1A3, whereas the tetrazole-N1 of this aglycone was accessible to other enzymes, including UGT1A5. Zolarsartan O-glucuronide was mainly produced by UGTs 1A10 and 2B7. UGT2...Continue Reading


Jan 1, 1994·British Journal of Pharmacology·A HilditchM J Robertson
Feb 1, 1994·Rapid Communications in Mass Spectrometry : RCM·G D BowersJ Oxford
Nov 27, 1999·Drug Metabolism Reviews·A Radominska-PandyaP I Mackenzie
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R H Tukey, C P Strassburg
Jul 24, 2001·Current Drug Metabolism·C D KingT R Tephly
Jul 24, 2001·Current Drug Metabolism·B C SallustioR L Nation
May 23, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miki NakajimaTsuyoshi Yokoi
Jan 28, 2003·Therapeutic Drug Monitoring·Maria ShipkovaEberhard Wieland
Apr 11, 2003·Chemico-biological Interactions·Mark J Bailey, Ronald G Dickinson
Jun 20, 2003·The Pharmacogenomics Journal·C Guillemette
Jan 7, 2004·Drug Metabolism Reviews·Mohamed OuzzineSylvie Fournel-Gigleux
Dec 14, 2004·Cardiovascular Drug Reviews·Christoph H GleiterKlaus Mörike
Feb 4, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anna AlonenRisto Kostiainen
Mar 23, 2005·Pharmacology & Therapeutics·Tony K L KiangThomas K H Chang
Aug 27, 2005·The Journal of Pharmacology and Experimental Therapeutics·Moshe FinelAnna Radominska-Pandya
Sep 6, 2005·Pharmacogenetics and Genomics·Peter I MackenzieDaniel W Nebert
Apr 8, 2006·Science·John Travis
Nov 28, 2006·Journal of Medicinal Chemistry·Andrew V StachulskiIan D Wilson
Feb 5, 2008·The Journal of Thoracic and Cardiovascular Surgery·Peter MattHarry C Dietz

❮ Previous
Next ❯


Oct 4, 2011·Drug Metabolism Reviews·Baojian Wu
Oct 23, 2014·Drug Metabolism Reviews·Dong Gui HuPeter I Mackenzie
Sep 15, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Neil AttkinsAnne C Heatherington
Mar 26, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Sanna KaivosaariMikko Koskinen
Jun 23, 2015·Biopharmaceutics & Drug Disposition·Yongsheng XiaoLushan Yu
Aug 29, 2009·Gastroenterología y hepatología·Manuel Jiménez-SáenzJuan M Herrerías
Jul 19, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Eun-Sook JeongDong-Hyun Kim
Apr 4, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Zhufeng WuBaojian Wu
May 2, 2012·Biochimica Et Biophysica Acta·Paula S Montenegro-MirandaPiter J Bosma
Mar 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ju-Hyun KimHye Suk Lee
Apr 17, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tae Yeon KongHye Suk Lee
Jul 30, 2014·Chirality·Edyta Łukowska-Chojnacka, Jolanta Mierzejewska
Mar 31, 2018·Angewandte Chemie·Margit WinklerAnton Glieder
Jan 4, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yannick ParmentierBernard Walther
Feb 7, 2019·Physiological Reviews·Robyn MeechPeter I Mackenzie
Jan 30, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Kishore K Katyayan, Yu-Hua Hui
Oct 10, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael A Zientek, Kuresh Youdim
Jan 16, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yurie KatsubeKohshi Nishiguchi

❮ Previous
Next ❯

Related Concepts

Related Feeds


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.